| |
| |
|
| Insider
Information: |
Olukotun Adeoye Y |
| Relationship: |
Director |
| City: |
Ann Arbor |
| State: |
MI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
93,786 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$577,328 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
93,786 |
|
|
| Total
Value |
$577,328 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -13.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Corautus Genetics Inc |
VEGF |
Chief Medical Officer |
2007-06-05 |
59,624 |
2007-06-05 |
0 |
Premium* |
|
|
Icagen Inc |
ICGN |
Director |
2011-10-27 |
0 |
2009-03-05 |
0 |
Premium* |
|
|
Diadexus Inc |
DDXS |
Director |
2013-08-06 |
5,958 |
2013-08-06 |
0 |
Premium* |
|
|
Tonix Pharmaceuticals Holding Corp |
TNXP |
Director |
2020-08-13 |
5,350 |
2020-08-13 |
0 |
Premium* |
|
|
Arrowhead Pharmaceuticals Inc |
ARWR |
Director |
2023-12-15 |
22,854 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2023-12-15 |
4 |
A |
$25.41 |
$380,820 |
D/D |
14,987 |
22,854 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2023-03-03 |
4 |
S |
$32.65 |
$370,578 |
D/D |
(11,350) |
7,867 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2023-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,867 |
19,217 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2022-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
6,400 |
11,350 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2022-01-03 |
4 |
AS |
$64.26 |
$262,233 |
D/D |
(4,050) |
4,950 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2021-09-13 |
4 |
AS |
$63.76 |
$318,800 |
D/D |
(5,000) |
9,000 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2021-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
14,000 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2020-09-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
% |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2020-08-13 |
4 |
B |
$0.94 |
$5,029 |
D/D |
5,350 |
5,350 |
2.39 |
- |
|
| DDXS |
Diadexus Inc |
Director |
– • – |
2013-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,958 |
5,958 |
0 |
- |
|
| ICGN |
Icagen Inc |
Director |
– • – |
2011-10-27 |
4 |
D |
$6.00 |
$42,372 |
D/D |
(7,062) |
0 |
0 |
- |
|
| ICGN |
Icagen Inc |
Director |
– • – |
2011-09-02 |
4 |
D |
$6.00 |
$66,846 |
D/D |
(11,141) |
7,062 |
0 |
- |
|
| ICGN |
Icagen Inc |
Director |
– • – |
2011-09-02 |
4 |
OE |
$2.56 |
$14,420 |
D/D |
4,500 |
18,203 |
0 |
- |
|
| ICGN |
Icagen Inc |
Director |
– • – |
2011-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,062 |
13,703 |
0 |
- |
|
| ICGN |
Icagen Inc |
Director |
– • – |
2010-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
26,539 |
53,134 |
0 |
- |
|
| ICGN |
Icagen Inc |
Director |
– • – |
2009-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
26,595 |
26,595 |
0 |
- |
|
| VEGF |
Corautus Genetics Inc |
Chief Medical Officer |
• – – |
2007-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
59,624 |
59,624 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
